Enimmune Corporation (6564.TWO) Stock
—
Valuation
Financials & Margins
Valuation & Return Ratios
About Enimmune Corporation
—
Enimmune Corporation is led by CEO Zhe Wei Zhang, employs 27 people, headquartered in Taipei, TW, publicly traded since 2018.
Enimmune Corporation (6564.TWO) stock trades at $16.05 with a market capitalization of $1.18B. The stock is valued at a negative price-to-earnings (P/E) ratio of -9.79, reflecting a net loss over the last twelve months, price-to-book of 11.75, price-to-sales of 22.07. Over the past 52 weeks the stock has ranged between $14.90 and $23.90, and currently trades 32.8% below its 52-week high.
On profitability, Enimmune Corporation generates a return on equity (ROE) of -74.45% (negative, reflecting a net loss), an operating margin of -174.71%, a net profit margin of -226.16%.
Official website: www.enimmune.com.tw
Enimmune Corporation (6564.TWO) — frequently asked questions
What is Enimmune Corporation (6564.TWO) stock price today?
Enimmune Corporation (6564.TWO) is currently trading at $16.05, down 0.62% today.
What is 6564.TWO P/E ratio?
Enimmune Corporation's P/E ratio is -9.79. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 6564.TWO return on equity (ROE)?
Enimmune Corporation's return on equity (ROE) is -74.45%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Enimmune Corporation's market cap?
Enimmune Corporation has a market capitalization of $1.18B.
Does 6564.TWO pay a dividend?
Enimmune Corporation is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 6564.TWO carry?
Enimmune Corporation has a debt-to-equity ratio of 1.59. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 6564.TWO's profit margin?
Enimmune Corporation reports a net profit margin of -226.16% — the share of revenue left after every cost, including tax and interest.
What sector is 6564.TWO in?
Enimmune Corporation is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 6564.TWO listed on?
Enimmune Corporation trades on TWO under the ticker 6564.TWO.
What is 6564.TWO's 52-week range?
Over the last year Enimmune Corporation has traded between $14.90 and $23.90.
Related — Stocks
Popular Stocks
Screens 6564.TWO currently matches
On the figures above, Enimmune Corporation passes the filters for 3 of our ready-made screens, among them Small Cap Stocks, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.